thioflavin t has been researched along with Hepatitis B in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cianciara, J; Laskus, T | 1 |
| Baj, Z; Dworniak, D; Pokoca, L; Tchórzewski, H; Tkacz, B | 1 |
| Baj, Z; Drobnik, S; Dworniak, D; Luciak, M; Pokoca, L; Tchórzewski, H; Tkacz, B | 1 |
| Adamek, J; Juszczyk, J; Kiczka, W | 1 |
2 trial(s) available for thioflavin t and Hepatitis B
| Article | Year |
|---|---|
Thymic factor X treatment of chronic hepatitis B.
Topics: Chronic Disease; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Surface Antigens; Humans; Male; Thymosin; Thymus Extracts; Time Factors | 1992 |
[Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Thymus Extracts | 1987 |
2 other study(ies) available for thioflavin t and Hepatitis B
| Article | Year |
|---|---|
The effect of long-term thymosine factor x/TFx/treatment on T lymphocyte subpopulations and peripheral blood mononuclear cell cytotoxicity in chronic active hepatitis B.
Topics: Adolescent; Adult; Cytotoxicity, Immunologic; Female; Hepatitis B; Hepatitis, Chronic; Humans; In Vitro Techniques; Killer Cells, Natural; Male; Middle Aged; T-Lymphocyte Subsets; Thymus Extracts; Time Factors | 1991 |
Treatment with thymic extract TFX for chronic active hepatitis B.
Topics: Adolescent; Adult; CD4-CD8 Ratio; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis, Chronic; Humans; Immunoglobulins; Killer Cells, Natural; Male; Middle Aged; Thymus Extracts | 1991 |